Wave Life Sciences shares soared more than 70% on Wednesday after the biotech firm said it had successfully edited the RNA of patients with a genetic disorder that can lead to lung or liver disease. T …
Wave Life Sciences Stock Climbs on RNA Editing Progress
view original post